Table 2.
Clinical and biological data collection planning
| D0* | D1 (D2†) | D2‡ | D3/4 | D5/7 | D13/18 | D26/36 | D52/68 | D90 | |
| Inclusion/exclusion criteria | x§ | ||||||||
| Consent form | x§ | ||||||||
| Demography | x§ | ||||||||
| Weight | x§ | ||||||||
| Size | x§ | ||||||||
| Description of hospital stay | x§ | ||||||||
| IGS II score | x§ | ||||||||
| McCabe score | x§ | ||||||||
| CHARLSON score | x§ | ||||||||
| Documentation of the | x§ | ||||||||
| septic shock, surgery, | |||||||||
| burn or trauma | |||||||||
| SOFA score | x | x | x | x | X | ||||
| Treatments against infections | Steadily | x | x | x | x | ||||
| Therapeutic management | Steadily | ||||||||
| Exposition to medical devices | Steadily | ||||||||
| Surveillance of healthcare | Steadily | x¶ | x¶ | x¶ | x¶ | ||||
| associated infections | |||||||||
| Concomitant events | Steadily | x | x | x | x | ||||
| Vital status** | x | x | x | x | |||||
| Life quality (EQ5D) | x | ||||||||
| Biology | |||||||||
| PAXgene tube sampling | x | x | x | x | X | x | x | x | |
| EDTA tubes sampling | x | x | x | x | X | x | x | x | |
| Heparin tubes sampling | x | x | x | x | X | x | x | x | |
| Haematology | x | x | x | x | X | x | x | x | |
| Lactate | x†† | x†† | x†† | x†† | x†† | ||||
| pH | x†† | x†† | x†† | x†† | x†† | ||||
| Liver results (ASAT, ALAT, PAL) | x†† | x†† | x†† | x†† | x†† | ||||
| Procalcitonin | x†† | x†† | x†† | x†† | x†† | x†† | x†† | x†† | x†† |
| Serology (CMV, HSV1) | X§ | ||||||||
*Only for patients of the surgery group
†For the septic shock and burn patients: The enrollment at D2 will be accepted if D1 is not available
‡Only for patients of the trauma group
§Evaluation on day 0 for patients of the surgery group (not repeated on day 1)
¶Only if related to a new hospitalisation
**Also at ICU release and Hospital release
††If available